Abstract
Human connectome studies have provided abundant data consistent with the hypothesis that functional dysconnectivity is predominant in psychosis spectrum disorders. Converging lines of evidence also suggest an interaction between dorsal anterior cingulate cortex (dACC) cortical glutamate with higher-order functional brain networks (FC) such as the default mode (DMN), dorsal attention (DAN), and executive control networks (ECN) in healthy controls (HC) and this mechanism may be impaired in psychosis. Data from 70 antipsychotic-medication naïve first-episode psychosis (FEP) and 52 HC were analyzed. 3T Proton magnetic resonance spectroscopy (1H-MRS) data were acquired from a voxel in the dACC and assessed correlations (positive FC) and anticorrelations (negative FC) of the DMN, DAN, and ECN. We then performed regressions to assess associations between glutamate + glutamine (Glx) with positive and negative FC of these same networks and compared them between groups. We found alterations in positive and negative FC in all networks (HC > FEP). A relationship between dACC Glx and positive and negative FC was found in both groups, but when comparing these relationships between groups, we found contrasting associations between these variables in FEP patients compared to HC. We demonstrated that both positive and negative FC in three higher-order resting state networks are already altered in antipsychotic-naïve FEP, underscoring the importance of also considering anticorrelations for optimal characterization of large-scale functional brain networks as these represent biological processes as well. Our data also adds to the growing body of evidence supporting the role of dACC cortical Glx as a mechanism underlying alterations in functional brain network connectivity. Overall, the implications for these findings are imperative as this particular mechanism may differ in untreated or chronic psychotic patients; therefore, understanding this mechanism prior to treatment could better inform clinicians.
Clinical trial registration: Trajectories of Treatment Response as Window into the Heterogeneity of Psychosis: A Longitudinal Multimodal Imaging Study, NCT03442101. Glutamate, Brain Connectivity and Duration of Untreated Psychosis (DUP), NCT02034253.
Similar content being viewed by others
Introduction
Studies of the human connectome have provided an abundance of data consistent with the hypothesis that dysconnectivity, the aberrant integration of functional brain networks, is fundamental in psychosis spectrum disorders [1,2,3]. The dysconnectivity model posits that psychosis can be better understood from a neurobiological perspective since N-methyl-d-aspartate receptor (NMDAR) functioning moderates disturbances in the synaptic efficacy affecting the excitation/inhibition balance thus affecting the intrinsic (local) and extrinsic (long-range) connectivity of functional brain networks [4]. Consistent with this, recent studies have found that cortical glutamate plays an important role in modulating the blood-oxygen-level-dependent (BOLD) signal [5] and functional connectivity [6], and pharmacological challenge studies have also found a disruption in functional brain networks following experimentally induced NMDAR hypofunction in healthy human subjects [6,7,8]. Taken together, it is plausible that cortical glutamate may play an important modulatory role in functional brain network dysconnectivity observed in psychosis spectrum disorders [9,10,11,12].
We recently reported the results of a multimodal neuroimaging study in antipsychotic-medication naïve first episode psychosis patients (FEP) where we used proton magnetic resonance spectroscopy (1H-MRS) to quantify cortical glutamate + glutamine (Glx) in the dorsal anterior cingulate cortex (dACC) and resting-state functional magnetic resonance imaging (fMRI) to assess functional connectivity in the salience network (SN, which spans across the dACC and the anterior insula) [13]. Our principal finding, reduced salience network connectivity in FEP and the lack of a robust relationship between glutamate and connectivity that is present in healthy subjects is in agreement with the dysconnectivity hypothesis from our findings of dACC cortical Glx playing a modulatory role in functional brain connectivity in psychosis at a local level.
Because a number of functional networks that support higher-order cognitive functioning have been implicated in the schizophrenia pathophysiology [14,15,16,17,18,19], and cortical Glx may not only have local effects as previously shown by our previous study but may also modulate long-range functional connectivity of higher-order functional brain networks in FEP as this has been previously observed in healthy individuals [20, 21], we chose to expand this line of investigation using an overlapping sample and interrogate putative associations between dACC cortical Glx and relevant higher-order functional brain networks: default mode (DMN), executive control (ECN), and dorsal attention network (DAN). These higher-order functional brain networks were chosen as they are responsible for specific cognitive functioning known to be impaired in schizophrenia [22]. We investigated both correlations and anti-correlations of these higher-order functional brain networks. Anticorrelations were considered in our analyses because the presence of anticorrelated networks has been described at rest [23] and functional connectome data-based modeling has highlighted the importance of anticorrelations for optimal characterization of higher-order functional brain network connectivity [24]. Additionally, reduced anticorrelations may be regarded as signs of decreased brain flexibility/inhibition to react upon external stimuli consequently altering cortical glutamate activity [25, 26]. We hypothesized that dysconnectivity in the DMN, ECN, and the DAN is present for both correlations and anticorrelations in antipsychotic-naïve FEP and that there would be a strong relationship between dACC cortical Glx and functional connectivity in higher-order functional brain networks in healthy controls (HC), but this relationship would be weaker in FEP.
Materials and methods
Participants
A total of 127 (HC = 54; FEP = 73) subjects participated in this study. FEP patients were recruited from outpatient clinics, inpatient units, and the emergency room at the University of Alabama at Birmingham (UAB). Studies were approved by the UAB Institutional Review Board, and written informed consent was obtained before enrollment (patients had to be deemed competent to provide consent) [27]. Exclusion criteria were major neurological or medical conditions, history of significant head trauma, substance use disorders (excluding nicotine and cannabis) within 1 month of imaging, more than five days of lifetime antipsychotic exposure, pregnancy or breastfeeding, and MRI contraindications. Consensus diagnoses were made according to DSM-5 criteria by two board-certified psychiatrists from all historical and direct assessment information available (ACL and NVK). Because FEP subjects were followed over several months, consensus diagnosis was also based on this longitudinal assessment. The Brief Psychiatric Rating Scale (BPRS) and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) were used to assess symptom severity and cognition [28, 29]. We also recruited healthy controls (HC) from flyers and ads within UAB and the emergency room where we recruited our patients. HCs were matched on age, gender, and parental socioeconomic status (SES). In addition to the above-outlined criteria, HCs with a personal history or a family history of a psychiatric illness in a first-degree relative were also excluded.
Data acquisition
All imaging was performed on a 3T whole-body Siemens MAGNETOM Prisma MRI scanner equipped with a 20-channel head coil. A high-resolution T1-weighted structural scan was acquired for anatomical reference (MPRAGE: TR = 2400 ms; TE = 2.22 ms; inversion time = 1000 ms; flip angle = 8°; GRAPPA factor = 2; voxel size = 0.8 mm3). 1H-MRS data were collected from a voxel in the anterior cingulate cortex (27 × 20 × 10 mm3). Following automatic and manual shimming to optimize field homogeneity across the voxel, chemical shift selective (CHESS) pulses were used to suppress the water signal. Then, spectra were obtained using a point resolved Spectroscopy sequence (PRESS; TR/TE = 2000/80 ms, flip angle = 90°, vector size 1024, 96 averages [30, 31]). Moreover, 8 averages of unsuppressed water scans with the same acquisition parameters were acquired as an internal reference.
Finally, resting-state fMRI data was acquired in opposing phase encoding directions (anterior > posterior and posterior > anterior; TR = 1550 ms; TE = 37.80 ms; flip angle = 71°, FOV = 104 mm2; multi-band acceleration factor = 4; voxel size = 2 mm3; 225 volumes, and 72 axial slices). Subjects were instructed to look at a fixation cross, keep their eyes open, and let their mind wander.
Data preprocessing
Proton magnetic resonance spectroscopy data
All spectra were analyzed in jMRUI version 6.0 using the AMARES algorithm ([32]. The model consisted of peaks for N-Acetyl aspartate (NAA), choline (Cho), Creatine (Cr + Cr2), Glx was modeled as a triplet (large peak with 2 small outer wings) as previously described [33]. After removing the residual water peak using the Hankel–Lanczos singular values decomposition filter, the amplitude of the center Glx peak was estimated and Glx levels were calculated relative to the unsuppressed voxel water and expressed in institutional units (I.U.) [34]. Metabolite levels were corrected for partial volume effects (i.e. gray and white matter voxel content) according to Gasparovic and colleagues [35, 36]; the fraction of cerebrospinal fluid, gray and white matter was calculated by segmentation of the T1-weighted images in SPM8.
Exclusion criteria for Glx were the failure of the fitting algorithm, signal-to-noise ratio (SNR) < 3, full width at half maximum (FWHM) > 0.1 ppm [37], and Cramer–Rao lower bounds (CRLB) > 20%.
Resting-state fMRI data
After discarding the first 10 volumes of each scan allowing for signal equilibration, susceptibility artifacts were corrected using spin echo field maps in FSL’s top-up, and then the 2 corrected fMRI runs were combined resulting in a single 4D image of 430 total volumes [38]. Data were analyzed using the CONN toolbox version 20a https://web.conn-toolbox.org [39]. Functional images were slice-timing and motion-corrected using rigid-body realignment, co-registered to the structural image, normalized to Montreal Neurological Institute (MNI) space, bandpass filtered (0.008 < f < 0.08 Hz), and spatially smoothed with a 4-mm FWHM Gaussian kernel.
Framewise displacement (FD) and percentage of censored data were then calculated [40]. Motion outliers as detected by the artifact detection (ART) toolbox were censored (composite volume-to-volume motion > 0.5 mm and intensity >3 SDs), and the six motion parameters derived from rigid-body realignment and their derivatives, as well as the first 5 component time series derived from CSF and white matter using aCompCor and corresponding derivatives, were regressed out from the signal. No global signal regression was performed as this can impact functional connectivity analyses.
Statistical analyses
For connectivity analyses, three regions of interest (ROIs) within the CONN toolbox were used: DMN (posterior cingulate cortex, PCC), DAN (right intraparietal sulcus, RIPS), and ECN (right posterior parietal cortex, RPPC). Residual time-series from each ROI were extracted and correlated with every other voxel in the brain, creating individual whole-brain z-transformed correlation maps (positive FC). Anticorrelation (negative FC) maps of each network were also computed for each network. To restrict all analyses within each functional brain network, functional network masks were created by thresholding average correlation maps for each group to a minimum value of t = 10 for positive FC and t = −20 for negative FC and a cluster size of 100 voxels. Then, average masks using all combined groups (HC + FEP) were created for each network (Fig. 1). Group analyses were then performed in CONN, but to restrict all analyses to their respective brain network masks, small volume correction (p < 0.01 defined by α = 0.05/4 networks of interest; also accounting for the salience network, for results see ref. [13]) were performed by running threshold-free cluster enhancement (TFCE) [41]. TFCE correction estimates a voxel-wise metric that captures the amount of cluster-like local spatial support for activation, combined with non-parametric permutation testing for inference. Age, sex, and FD were treated as covariates.
To examine how dACC Glx plays a role in connectivity in all three networks, Glx values were entered into regression analyses to predict connectivity on each network. This was done for both positive and anticorrelated areas. Average Glx-FC maps of each subject for each group were entered into group analyses to test for interaction effects (how Glx-FC associations differ between HC and FEP) while controlling for age, gender, and FD. Multiple comparison correction was performed as described above.
Associations between dACC Glx and clinical scores were assessed in our previous study and found no significant correlations. For this study, exploratory analyses were performed where FC data was extracted from clusters of significant group differences (clusters from Fig. 1) and correlated with BPRS and RBANS subscales scores while controlling for age, sex, and FD. Given that these analyses are exploratory in fashion, no correction for multiple comparisons was applied and results should be taken with caution.
Results
Demographics and clinical data
After excluding five subjects with noisy MRS data, seven subjects with missing data/scans (did not have resting state scans), and seven subjects with excessive head motion (<50% of data remaining after censoring or volume-to-volume motion > 0.5 mm), our sample included 122 (HC = 52; FEP = 70). Mean values for CRLB for each metabolite are also shown in Table 1.
Demographic data were compared between groups using a series of independent-sample t-tests and Chi-squares. HC and FEP were well matched in terms of age, gender, and parental socioeconomic status, but FEP patients smoked more often than HC (p < 0.001).
Group differences in dACC Glx, network correlations and anticorrelations
As previously reported in ref. [13], dACC Glx did not differ between groups (F1, 104 = 0.57, p = 0.45).
DMN-positive FC was largely similar between groups showing connectivity with traditional DMN regions such as bilateral angular gyrus, medial prefrontal cortex, and precuneus. Negative FC shows a different contrast with what is expected to resemble DAN and other areas. (Supplementary Table 1, Fig. 1A). Group differences revealed FEP showing reduced negative FC in the inferior frontal and orbital gyrus compared to HC (TFCE corrected, Table 2, Fig. 2A).
Similarly, groups showed DAN positive FC between intraparietal sulcus with bilateral middle temporal areas, frontal eye fields, and middle frontal areas and negative FC shows strong anticorrelations with DMN regions (Supplementary Table 1, Fig. 1B). Group differences revealed FEP showing reduced positive FC in left supramarginal gyrus and reduced negative FC in the medial orbital cortex compared to HC (TFCE corrected, Table 2, Fig. 2B).
Finally, ECN-positive FC spanned across the bilateral posterior parietal cortex, inferior middle temporal cortex, as well as dorsal and medial frontal cortices. As for negative FC, strong anticorrelations were found in sensory processing areas such as motor and visual regions (Supplementary Table 1 and Fig. 1C). In this network, positive FC was reduced in FEP in right parietal, temporal, and frontal regions while negative FC was stronger in the parietal, temporal and motor cortices when compared to HC (TFCE corrected, Table 2, Fig. 2C).
Relationship between dACC cortical Glx and functional brain network connectivity
We found associations between dACC Glx and DMN positive FC in the medial prefrontal cortex, precuneus, and posterior cingulate cortex, and between Glx and DMN negative FC with the caudate nucleus in HC, while only two associations were found in the FEP group (Supplementary Table 2 and Supplementary Fig. 1). When directly comparing the relationships between dACC Glx and DMN positive FC between groups, we found a significant Glx-FC interaction within the bilateral precuneus. There were no significant Glx-FC interactions when examining Negative FC (TFCE corrected, Table 3, Fig. 3B).
A Example voxel placement in the dorsal anterior cingulate cortex in one subject and its spectrum. The black line is a collected spectrum, and the blue line is a model fit. Clusters of group Glx-FC interactions in both HC and FEP in B default mode network (positive FC), C dorsal attention (negative FC), and D executive control network (positive FC; all TFCE corrected). BOLD signal was extracted for data scatterplot visualization purposes. Glx glutamate + glutamine, TFCE threshold-free cluster enhancement, FC functional connectivity, HC healthy controls, FEP first episode psychosis.
In the DAN we found an association between dACC Glx and bilateral angular gyri and frontal areas in HC. We also found this correlation in FEP, but the spatial extent was more limited (Supplementary Table 2, Supplementary Fig. 2). An effect of Glx in DAN Negative FC was found in frontal pole areas and temporal gyri in both groups. However, when directly comparing the two groups no interaction effects were found between dACC Glx and positive FC, but when examining the relationship between dACC Glx and DAN negative FC, we found a a group interaction effect in the right superior frontal gyrus (TFCE corrected, Table 3, Fig. 3C).
Finally, we found an association between dACC Glx and ECN-positive FC in frontal and parietal areas in HC and FEP. ECN-negative FC showed a positive association with Glx in the postcentral gyrus and central opercular in HC and FEP as well (Supplementary Table 2 and Supplementary Fig. 3). When directly comparing the relationship between dACC Glx and ECN-positive FC between groups, we found three regions that showed an interaction effect in middle orbital, inferior frontal and temporal areas and no interaction effects were found between dACC Glx and negative FC (TFCE corrected, Table 3, Fig. 3D).
Post-hoc brain-behavior analyses
Correlational findings between FC with all BPRS and RBANS subscales scores are shown in Supplementary Table 3. Furthermore, given the heterogeneity of FEP, we also explored these associations in schizophrenia patients only.
Discussion
The main goals of our studies (current and [13]) were to characterize large-scale resting state networks, considering both correlations and anticorrelations, in antipsychotic-naïve patients suffering from a first psychotic episode and to investigate the role of dACC cortical Glx as a putative mechanism underlying alterations in functional connectivity. We first report that both groups show expected correlations (positive FC) and their corresponding anticorrelations (negative FC) on these brain networks from previous literature [42] with the exception of ECN where a large cluster in the visual cortex was found. Nonetheless, when comparing both groups, we found connectivity reductions in SN [13], DMN, ECN, and DAN in patients consistent with our hypothesis that dysconnectivity in large-scale functional networks supporting higher-order cognitive function is already evident in the early illness stages. We also found weaker negative FC of the DMN, ECN, and DAN in patients (but not in SN), extending the literature by demonstrating that spontaneous anticorrelated networks are already affected in antipsychotic naïve FEP. Importantly, Glx predicted positive and negative FC of all networks in healthy subjects and FEP. When directly contrasting the relationship between cortical Glx and connectivity between groups, we found inverse associations between these variables in patients compared to controls in both correlated and anticorrelated networks except in the DAN. Taken together, our data lend additional empirical support to the hypothesis that dACC cortical Glx plays a modulatory role in brain connectivity and point to a possible mechanism underlying dysconnectivity in psychosis not only at a local level as shown by our previous study, but at a global one.
Attempts have been made to characterize large-scale functional networks at rest in antipsychotic-naïve patients, despite evidence suggesting that functional network architecture is sensitive to neuromodulation [43,44,45,46] and dopamine targeting agents such as L-dopa, methylphenidate, and haloperidol affect functional connectivity in healthy subjects [43, 47, 48]. Our findings are generally consistent with network-level dysconnectivity evidence in FEP [49, 50] and demonstrate that alterations in patterns of correlations and anti-correlations in functional networks are not just a confound of antipsychotic medication exposure. Reduced connectivity in the DMN [49] and decreased resting state amplitudes of low-frequency fluctuations (ALFFs), a different measure of spontaneous synchronous neuronal activity, in areas of the DMN and ECN have also been reported in antipsychotic-naïve FEP [51]. A recent meta-analysis of higher-order resting state brain networks in early-stage psychosis patients reported widespread hypoconnectivity in the DMN, and mixed hypo- and hyperconnectivity in the ECN, but available data was much more limited for the ECN, and the authors concluded that further studies are required to draw any decisive conclusions about ECN connectivity in first episode psychosis [44]. In our study, only negative FC of the DMN showed a significant group difference in the same region reported by O’Neill and colleagues [44] while the ECN showed consistent reductions in connectivity and the greatest spatial extent of connectivity reductions across the three networks. Similar to Baker and colleagues who examined resting state ECN integrity across the psychosis spectrum, we did not see a relationship between aberrant connectivity and symptom severity [3]. Our findings of reduced positive and negative FC of the DAN in FEP compared to HC do not support our previous findings in unmedicated patients with schizophrenia where these showed increased resting-state brain connectivity [52]. Heterogeneity and illness chronicity in our previous sample could explain this discrepancy between findings (unmedicated vs. medication naïve FEP). In terms of our current findings, abnormal FC in the DAN may correspond to the concept of psychosis being a disorder of brain network organization, more specifically to these higher-order brain networks [44].
Anticorrelations are believed to be a product of healthy functional segregation, where excitatory and inhibitory mechanisms are at play. There is debate in the literature as to whether anticorrelations in resting state connectivity data are neurobiologically valid, or if they are artificially introduced by data preprocessing methods such as global signal regression (which was not performed in this study) [53]. Empirically testing the effects of different data processing strategies, Chai and colleagues concluded that anticorrelations observed in seed-defined resting-state networks cannot be fully attributed to artifacts introduced by global signal regression and might be neuronal in origin [54]. Lending additional support to interpreting anticorrelations as a manifestation of neuronal activity, simultaneous electrophysiological recordings of low field potentials in the cat homologs of task-positive and task-negative regions found that these were often anticorrelated [55] and computational simulations suggest the existence of spontaneous anticorrelated networks [56]. In schizophrenia, resting state anticorrelations have been found to be altered [57, 58] and shown moderate accuracy in differentiating patients from healthy controls using support vector machine approaches [59]. Interestingly, anticorrelations between the DMN and a task-positive network present in healthy subjects were absent in patients at high risk or ultrahigh risk for schizophrenia [60]. Attenuated anticorrelations between the DMN and ECN have also been observed during the performance of a working memory task in patients with schizophrenia [61], which is consistent with our finding of attenuated anticorrelations in functional brain networks. Taken together, data suggests a deficit of higher-order functional brain networks in psychosis spectrum disorders.
Because the administration of ketamine, a non-competitive NMDA receptor antagonist, can result in a comparable disruption of functional networks in HC, it is plausible that glutamate has a role in the altered organization of large-scale anticorrelated functional brain networks in schizophrenia [62]. Disruption in the excitation/inhibition balance may lead to an increase of excitability in cortical microcircuitry, affect connectivity in large-scale networks, and in turn result in behavioral abnormalities [63,64,65]. When empirically testing the role of dACC cortical Glx in the modulation of functional brain networks, we found that dACC Glx was associated with the strength of positive and negative FC in all networks in both groups. These associations have not only been confirmed in humans [21] but in animals as well [66]. These findings are in agreement with recent studies which found that dACC cortical Glx plays an important role in modulating the blood-oxygen-level-dependent (BOLD) signal and functional connectivity [5, 6, 67, 68], and extend the literature by demonstrating that Glx/Glutamate may also be relevant for resting state network pathology in psychosis spectrum disorders [11]. Examining group interactions, we noted that higher dACC Glx levels were associated with greater positive FC in the DMN as well as lower positive and negative FC in the ECN in controls, while the opposite was found in FEP, again suggesting that atypical coupling of large-scale networks may be affected by Glx. A recent meta-analysis by Zahid and colleagues where the neurofunctional correlates of glutamate in psychosis were examined revealed six studies using resting state fMRI and dACC cortical Glx and two did not find significant group interactions [10, 69], and the remaining four found group interactions like in our current analysis [13, 25, 70, 71]. More specifically, our previous findings [13] and Limongi’s of weaker FC-Glx interactions are consistent with these findings. From a neuroenergetics perspective, the brain uses large amounts of energy to support synaptic transmission among distal brain regions. This process is highly dependent on a critical balance between glucose (a proxy of brain activity) and glutamatergic activity, which makes this energy demand very efficient [72]. Therefore, these abnormalities observed in FC-Glx interactions may be a result of abnormal glucose and Glx activity in FEP.
Several strengths and limitations of this study are notable. We enrolled a large group of antipsychotic-naïve FEP patients, which allowed us to mitigate antipsychotic medication or illness chronicity confounds. We decided not to exclude patients with a history of cannabis use, as it is a major risk factor for developing psychosis and thus highly clinically relevant, and excluding these patients would have inadvertently biased our sample and limited the generalizability of our data. Our 1H-MRS acquisition sequence does have some drawbacks such as J-modulation and T2 relaxation effects on the spectrum as well as a water signal that is highly T2-weighted and sensitive to cerebrospinal fluid contamination [37], a significant advantage of these acquisition parameters is that it allows us put findings in the context of a number of our previous studies for which we used the same acquisition parameters [73,74,75]. Moreover, we use tissue correction to reduce this bias. Finally, Glx was quantified instead of glutamate, therefore, our findings may not completely generalize to strictly glutamatergic abnormalities in psychosis, the heterogeneity within our FEP sample, and associations between symptom severity and imaging variables.
Conclusions
In summary, we extended the literature by demonstrating that both correlations and anticorrelations in large-scale resting-state networks supporting higher-order cognition are already altered in antipsychotic-naïve patients suffering from a first psychotic episode, underscoring the importance of also considering anticorrelations for optimal characterization of higher-order functional brain networks in this population. Our data also adds to the growing body of evidence supporting the role of dACC cortical Glx as a mechanism underlying alterations in functional connectivity. Given the considerable illness burden in psychosis spectrum disorders and the limited efficacy of conventional antipsychotic medications, future studies investigating novel agents attenuating connectivity alterations, possibly via modulation of glutamatergic pathways, are direly needed in the field.
References
Pettersson-Yeo W, Allen P, Benetti S, McGuire P, Mechelli A. Dysconnectivity in schizophrenia: where are we now? Neurosci Biobehav Rev. 2011;35:1110–24.
van den Heuvel MP, Fornito A. Brain networks in schizophrenia. Neuropsychol Rev. 2014;24:32–48.
Baker JT, Holmes AJ, Masters GA, Yeo BT, Krienen F, Buckner RL, et al. Disruption of cortical association networks in schizophrenia and psychotic bipolar disorder. JAMA Psychiatry. 2014;71:109–18.
Friston K, Brown HR, Siemerkus J, Stephan KE. The disconnection hypothesis (2016). Schizophr Res. 2016;176:83–94.
Enzi B, Duncan NW, Kaufmann J, Tempelmann C, Wiebking C, Northoff G. Glutamate modulates resting state activity in the perigenual anterior cingulate cortex—a combined fMRI–MRS study. Neuroscience. 2012;227:102–9.
Kraguljac NV, Frolich MA, Tran S, White DM, Nichols N, Barton-McArdle A, et al. Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Mol Psychiatry. 2017;22:562–9.
Driesen NR, McCarthy G, Bhagwagar Z, Bloch M, Calhoun V, D’Souza DC, et al. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Mol Psychiatry. 2013;18:1199–204.
Fleming LM, Javitt DC, Carter CS, Kantrowitz JT, Girgis RR, Kegeles LS, et al. A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms. Neuroimage Clin. 2019;22:101739.
Falkenberg LE, Westerhausen R, Craven AR, Johnsen E, Kroken RA, EM LB, et al. Impact of glutamate levels on neuronal response and cognitive abilities in schizophrenia. Neuroimage Clin. 2014;4:576–84.
Shukla DK, Wijtenburg SA, Chen H, Chiappelli JJ, Kochunov P, Hong LE, et al. Anterior cingulate glutamate and GABA associations on functional connectivity in schizophrenia. Schizophr Bull. 2019;45:647–58.
Zahid U, Onwordi EC, Hedges EP, Wall MB, Modinos G, Murray RM, et al. Neurofunctional correlates of glutamate and GABA imbalance in psychosis: a systematic review. Neurosci Biobehav Rev. 2023;144:105010.
Zahid U, McCutcheon RA, Borgan F, Jauhar S, Pepper F, Nour MM, et al. The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: a (1)H-MRS study in first-episode psychosis patients. Front Psychiatry. 2022;13:967941.
Maximo JO, Briend F, Armstrong WP, Kraguljac N V, Lahti AC. Salience network glutamate and brain connectivity in medication-naive first episode patients—a multimodal magnetic resonance spectroscopy and resting state functional connectivity MRI study. Neuroimage Clin. 2021;32:102845.
Khadka S, Meda SA, Stevens MC, Glahn DC, Calhoun VD, Sweeney JA, et al. Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry. 2013;74:458–66.
Meda SA, Gill A, Stevens MC, Lorenzoni RP, Glahn DC, Calhoun VD, et al. Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry. 2012;71:881–9.
Sheffield JM, Repovs G, Harms MP, Carter CS, Gold JM, MacDonald Iii AW, et al. Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia. Neuropsychologia. 2015;73:82–93.
Orliac F, Naveau M, Joliot M, Delcroix N, Razafimandimby A, Brazo P, et al. Links among resting-state default-mode network, salience network, and symptomatology in schizophrenia. Schizophr Res. 2013;148:74–80.
Moran LV, Tagamets MA, Sampath H, O’Donnell A, Stein EA, Kochunov P, et al. Disruption of anterior insula modulation of large-scale brain networks in schizophrenia. Biol Psychiatry. 2013;74:467–74.
Wolf ND, Sambataro F, Vasic N, Frasch K, Schmid M, Schonfeldt-Lecuona C, et al. Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations. J Psychiatry Neurosci. 2011;36:366–74.
Duncan NW, Wiebking C, Northoff G. Associations of regional GABA and glutamate with intrinsic and extrinsic neural activity in humans—a review of multimodal imaging studies. Neurosci Biobehav Rev. 2014;47:36–52.
Kiemes A, Davies C, Kempton MJ, Lukow PB, Bennallick C, Stone JM, et al. GABA, glutamate and neural activity: a systematic review with meta-analysis of multimodal (1)H-MRS-fMRI studies. Front Psychiatry. 2021;12:644315.
Woodward ND, Rogers B, Heckers S. Functional resting-state networks are differentially affected in schizophrenia. Schizophr Res. 2011;130:86–93.
Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci USA. 2005;102:9673–8.
Parente F, Colosimo A. Anticorrelations between active brain regions: an agent-based model simulation study. Neural Plasticity. 2018;2018:6815040.
Overbeek G, Gawne TJ, Reid MA, Kraguljac NV, Lahti AC. A multimodal neuroimaging study investigating resting-state connectivity, glutamate and GABA at 7 T in first-episode psychosis. J Psychiatry Neurosci. 2021;46:E702–E710.
Overbeek G, Gawne TJ, Reid MA, Salibi N, Kraguljac NV, White DM, et al. Relationship between cortical excitation and inhibition and task-induced activation and deactivation: a combined magnetic resonance spectroscopy and functional magnetic resonance imaging study at 7 T in first-episode psychosis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:121–30.
Carpenter WT Jr., Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, et al. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry. 2000;57:533–8.
Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10:799–812.
Randolph C, Tierney MC, Mohr E, Chase TN. The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20:310–9.
Schubert F, Gallinat J, Seifert F, Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage. 2004;21:1762–71.
Mullins PG, Chen H, Xu J, Caprihan A, Gasparovic C. Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites. Magn Reson Med. 2008;60:964–9.
Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129:35–43.
Kraguljac NV, White DM, Reid MA, Lahti AC. Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. JAMA Psychiatry. 2013;70:1294–302.
Scheidegger O, Wingeier K, Stefan D, Graveron-Demilly D, van Ormondt D, Wiest R, et al. Optimized quantitative magnetic resonance spectroscopy for clinical routine. Magn Reson Med. 2013;70:25–32.
Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG, et al. Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med. 2006;55:1219–26.
Gussew A, Erdtel M, Hiepe P, Rzanny R, Reichenbach JR. Absolute quantitation of brain metabolites with respect to heterogeneous tissue compositions in (1)H-MR spectroscopic volumes. MAGMA. 2012;25:321–33.
Wilson M, Andronesi O, Barker PB, Bartha R, Bizzi A, Bolan PJ, et al. Methodological consensus on clinical proton MRS of the brain: review and recommendations. Magn Reson Med. 2019;82:527–50.
Glasser MF, Sotiropoulos SN, Wilson JA, Coalson TS, Fischl B, Andersson JL, et al. The minimal preprocessing pipelines for the Human Connectome Project. Neuroimage. 2013;80:105–24.
Whitfield-Gabrieli S, Nieto-Castanon A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2012;2:125–41.
Power JD, Mitra A, Laumann TO, Snyder AZ, Schlaggar BL, Petersen SE. Methods to detect, characterize, and remove motion artifact in resting state fMRI. Neuroimage. 2014;84:320–41.
Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009;44:83–98.
Martinez-Gutierrez E, Jimenez-Marin A, Stramaglia S, Cortes JM. The structure of anticorrelated networks in the human brain. Front Netw Physiol. 2022;2:946380.
Cole DM, Beckmann CF, Oei NY, Both S, van Gerven JM, Rombouts SA. Differential and distributed effects of dopamine neuromodulations on resting-state network connectivity. Neuroimage. 2013;78:59–67.
O’Neill A, Mechelli A, Bhattacharyya S. Dysconnectivity of large-scale functional networks in early psychosis: a meta-analysis. Schizophr Bull. 2019;45:579–90.
van de Ven V, Wingen M, Kuypers KP, Ramaekers JG, Formisano E. Escitalopram decreases cross-regional functional connectivity within the default-mode network. PLoS ONE. 2013;8:e68355.
Schaefer A, Burmann I, Regenthal R, Arelin K, Barth C, Pampel A, et al. Serotonergic modulation of intrinsic functional connectivity. Curr Biol. 2014;24:2314–8.
Sripada CS, Kessler D, Welsh R, Angstadt M, Liberzon I, Phan KL, et al. Distributed effects of methylphenidate on the network structure of the resting brain: a connectomic pattern classification analysis. Neuroimage. 2013;81:213–21.
Cole DM, Oei NY, Soeter RP, Both S, van Gerven JM, Rombouts SA, et al. Dopamine-dependent architecture of cortico-subcortical network connectivity. Cereb Cortex. 2013;23:1509–16.
Gong Q, Hu X, Pettersson-Yeo W, Xu X, Lui S, Crossley N, et al. Network-level dysconnectivity in drug-naive first-episode psychosis: dissociating transdiagnostic and diagnosis-specific alterations. Neuropsychopharmacology. 2017;42:933–40.
Li T, Wang Q, Zhang J, Rolls ET, Yang W, Palaniyappan L, et al. Brain-wide analysis of functional connectivity in first-episode and chronic stages of schizophrenia. Schizophr Bull. 2017;43:436–48.
Ren W, Lui S, Deng W, Li F, Li M, Huang X, et al. Anatomical and functional brain abnormalities in drug-naive first-episode schizophrenia. Am J Psychiatry. 2013;170:1308–16.
Kraguljac NV, White DM, Hadley JA, Visscher K, Knight D, ver Hoef L, et al. Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone. Neuroimage Clin. 2016;10:146–58.
Weissenbacher A, Kasess C, Gerstl F, Lanzenberger R, Moser E, Windischberger C. Correlations and anticorrelations in resting-state functional connectivity MRI: a quantitative comparison of preprocessing strategies. Neuroimage. 2009;47:1408–16.
Chai XJ, Castanon AN, Ongur D, Whitfield-Gabrieli S. Anticorrelations in resting state networks without global signal regression. Neuroimage. 2012;59:1420–8.
Popa D, Popescu AT, Pare D. Contrasting activity profile of two distributed cortical networks as a function of attentional demands. J Neurosci. 2009;29:1191–201.
Honey CJ, Kotter R, Breakspear M, Sporns O. Network structure of cerebral cortex shapes functional connectivity on multiple time scales. Proc Natl Acad Sci USA. 2007;104:10240–5.
Chai XJ, Whitfield-Gabrieli S, Shinn AK, Gabrieli JD, Nieto Castanon A, McCarthy JM, et al. Abnormal medial prefrontal cortex resting-state connectivity in bipolar disorder and schizophrenia. Neuropsychopharmacology. 2011;36:2009–17.
Mueller S, Wang D, Pan R, Holt DJ, Liu H. Abnormalities in hemispheric specialization of caudate nucleus connectivity in schizophrenia. JAMA Psychiatry. 2015;72:552–60.
Ramkiran S, Sharma A, Rao NP. Resting-state anticorrelated networks in Schizophrenia. Psychiatry Res Neuroimaging. 2019;284:1–8.
Wotruba D, Michels L, Buechler R, Metzler S, Theodoridou A, Gerstenberg M, et al. Aberrant coupling within and across the default mode, task-positive, and salience network in subjects at risk for psychosis. Schizophr Bull. 2014;40:1095–104.
Whitfield-Gabrieli S, Thermenos HW, Milanovic S, Tsuang MT, Faraone SV, McCarley RW, et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci USA. 2009;106:1279–84.
Anticevic A, Gancsos M, Murray JD, Repovs G, Driesen NR, Ennis DJ, et al. NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci USA. 2012;109:16720–5.
Krystal JH, D’Souza DC, Mathalon D, Perry E, Belger A, Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology. 2003;169:215–33.
Uhlhaas PJ. Dysconnectivity, large-scale networks and neuronal dynamics in schizophrenia. Curr Opin Neurobiol. 2013;23:283–90.
Deco G, Ponce-Alvarez A, Hagmann P, Romani GL, Mantini D, Corbetta M. How local excitation-inhibition ratio impacts the whole brain dynamics. J Neurosci. 2014;34:7886–98.
Hyder F, Patel AB, Gjedde A, Rothman DL, Behar KL, Shulman RG. Neuronal-glial glucose oxidation and glutamatergic-GABAergic function. J Cereb Blood Flow Metab. 2006;26:865–77.
Kapogiannis D, Reiter DA, Willette AA, Mattson MP. Posteromedial cortex glutamate and GABA predict intrinsic functional connectivity of the default mode network. Neuroimage. 2013;64:112–9.
Duncan NW, Wiebking C, Tiret B, Marjanska M, Hayes DJ, Lyttleton O, et al. Glutamate concentration in the medial prefrontal cortex predicts resting-state cortical-subcortical functional connectivity in humans. PLoS ONE. 2013;8:e60312.
Li J, Ren H, He Y, Li Z, Ma X, Yuan L, et al. Anterior cingulate cortex glutamate levels are related to response to initial antipsychotic treatment in drug-naive first-episode schizophrenia patients. Front Psychiatry. 2020;11:553269.
Limongi R, Jeon P, Mackinley M, Das T, Dempster K, Theberge J, et al. Glutamate and dysconnection in the salience network: neurochemical, effective connectivity, and computational evidence in schizophrenia. Biol Psychiatry. 2020;88:273–81.
McCutcheon RA, Pillinger T, Rogdaki M, Bustillo J, Howes OD. Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls. Transl Psychiatry. 2021;11:322.
Tomasi D, Wang GJ, Volkow ND. Energetic cost of brain functional connectivity. Proc Natl Acad Sci USA. 2013;110:13642–7.
Kraguljac NV, Morgan CJ, Reid MA, White DM, Jindal RD, Sivaraman S, et al. A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia. Schizophr Res. 2019;210:239–44.
Kraguljac NV, Reid MA, White DM, den Hollander J, Lahti AC. Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. Neuropsychopharmacology. 2012;37:2635–42.
Reid MA, Salibi N, White DM, Gawne TJ, Denney TS, Lahti AC. 7T Proton magnetic resonance spectroscopy of the anterior cingulate cortex in first-episode schizophrenia. Schizophr Bull. 2019;45:180–9.
Briend F, Armstrong WP, Kraguljac NV, Keilhloz SD, Lahti AC. Aberrant static and dynamic functional patterns of frontoparietal control network in antipsychotic-naive first-episode psychosis subjects. Hum Brain Mapp. 2020;41:2999–3008.
Kraguljac NV, Anthony T, Morgan CJ, Jindal RD, Burger MS, Lahti AC. White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients. Mol Psychiatry. 2021;26:5347–56.
Maximo JO, Nelson EA, Armstrong WP, Kraguljac NV, Lahti AC. Duration of untreated psychosis correlates with brain connectivity and morphology in medication-naive patients with first-episode psychosis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020;5:231–8.
Nelson EA, Kraguljac NV, Maximo JO, Briend F, Armstrong W, Ver Hoef LW, et al. Hippocampal dysconnectivity and altered glutamatergic modulation of the default mode network: a combined resting-state connectivity and magnetic resonance spectroscopy study in schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022;7:108–18.
Acknowledgements
Special thanks to the patients and their families.
Funding
This work was supported by the National Institutes of Health (R01MH102951 and R01MH113800).
Author information
Authors and Affiliations
Contributions
ACL had full access to all the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: ACL. Acquisition of data: WPA, NVK. Analysis and interpretation of data: All authors. Drafting of the manuscript: JOM, FMB, NVK, ACL. Statistical analysis: JOM. Obtained funding: ACL. Administrative, technical, or material support: ACL. Study supervision: ACL.
Corresponding author
Ethics declarations
Competing interests
NVK serves as a consultant for Neurocrine Biosciences, Inc. All other authors declare no competing interest including relevant financial interests, activities, relationships, and affiliations.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Maximo, J.O., Briend, F., Armstrong, W.P. et al. Higher-order functional brain networks and anterior cingulate glutamate + glutamine (Glx) in antipsychotic-naïve first episode psychosis patients. Transl Psychiatry 14, 183 (2024). https://doi.org/10.1038/s41398-024-02854-7
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41398-024-02854-7
- Springer Nature Limited